Products
The Model ORCA-2016CN Clinical Unit is a portable Patient Isolation Unit (PIU) designed to prevent chemical and particulate (biological and radiological) cross-contamination between an enclosed patient and the external environment during evacuation and transport activities. It has been optimized for use in marine environments and for hoisting operations employing the Stokes litter. Use of the ORCA-2016CN allows safe transport of contaminated patients who have been medically stabilized, while protecting boat and cutter crews, aircrews, passengers, auxiliary care providers, and transport assets. The ORCA™ Clinical Unit is intended for:
• Isolated transport of medically stabilized patients on aircraft, ambulances, ships, or any vehicle capable of safely transporting a patient on either a Stokes or a NATO standard litter.
• Use with the Stokes litter to hoist and evacuate patients from ships or other marine platforms by rotary wing aircraft.
• Temporary isolation with or without transport of patients within hospitals or other medical facilities.
Model ORCA-2016CN – for Single Clinical Use. Patent Pending.
Available on GSA contract GS-07F-037GA
CAPSULS™ is a portable patient isolation unit (PIU) which prevents particulate (biological and radiological) cross-contamination between the patient and the external environment. This unit includes features that enable medical intervention to the patient via end-user supplied medical equipment. CAPSULS™ is intended to be used in the:
• Transportation and isolation of patients on aircraft, ambulances, ships, and any vehicle capable of safely relocating a patient on a standard litter.
• Temporary isolation with or without transport of patients within hospitals or other medical facilities.
CAPSULS™ is a Regulatory Class II device. It has been cleared by the FDA for marketing in the U.S. (510(k) K052798) as well as in Europe. U.S. Patent: 6,241,653
*We recommend purchasing a training unit in conjuction with a CAPSULS clinical unit to help facilitate proper usage in a potential CBRN incident.
CBAG™ CHRPs are flexible, 3-dimensional, and man-portable. They employ a superior CBR barrier system to provide unsurpassed protection against cross contamination from the remains to personnel, equipment, facilities, and transport assets. CBAG™ CHRPs can be used stand-alone for transport and for the temporary isolation, storage, and direct burial of remains. They may also be used for permanent burial of contaminated remains within conventional caskets.
CBAG™ Model 2005CB-PUR - U.S. Patent 9,290,305 B2. A U.S. patent is pending on CBAG™ Model 2K10CB-BIO.
